Clinicoradiological profile and serum lipid levels of intracerebral hemorrhage in prior statin users

Internal Medicine

Volumn 50, Issue 13, 2011, Pages 1385-1391

  Miura, Ken ^a   Yoshii, Yasuhiro ^a   Nakamura, Yoshikazu ^a   Ikeda, Ken ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

Author keywords

Cardiovascular disease risk factor; Functional outcome; Hematoma volume; Intracerebral hemorrhage; Serum total cholesterol levels; Statin

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE; AGED; ARTICLE; BLOOD PRESSURE; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; DYSLIPIDEMIA; FEMALE; HEART ATRIUM FIBRILLATION; HEMATOMA; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; RANKIN SCALE; RETROSPECTIVE STUDY; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79960047592     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5144     Document Type: Article

References (32)

1. Sacco RL, Liao JK. Drug insight: Statins and stroke. Nat Clin Pract Cardiovasc Med 2: 576-584, 2005.
2. Endres M, Laufs U, Huang Z, et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95: 8880-8885, 1998.
3. Jung KH, Chu K, Jeong SW, et al. HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. Stroke 35: 1744-1749, 2004.
4. Seyfried D, Han Y, Lu D, Chen J, Bydon A, Chopp M. Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats. J Neuro-surg 101: 104-107, 2004.
5. Lu D, Mahmood A, Qu C, Goussev A, Lu M, Chopp M. Atorvas-tatin reduction of intracranial hematoma volume in rats subjected to controlled cortical impact. J Neurosurg 101: 822-825, 2004.
6. McGirt MJ, Lynch JR, Parra A, et al. Simvastatin increases endo-thelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33: 2950-2956, 2002.
7. McGirt MJ, Pradilla G, Legnani FG, et al. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery 58: 945-951, 2006.
8. Iwamoto K, Yoshii Y, Ikeda K. Atorvastatin treatment attenuates motor neuron degeneration in wobbler mice. Amyotroph lateral Scler 10: 405-409, 2009.
9. Marti-Fabregas J, Gomis M, Arboix A, et al. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 35: 1117-1121, 2004.
10. Tseng MY, Hutchinson PJ, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 38: 1545-1550, 2007.
11. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med 344: 1450-1460, 2001.
12. Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemor-rhagic stroke in the Honolulu Heart Program. Stroke 20: 1460-1465, 1989.
13. Iribarren C, Reed DM, Burchfiel CM, Dwyer JH. Serum total cholesterol and mortality. Confounding factors and risk modification in Japanese-American men. JAMA 273: 1926-1932, 1995.
14. Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth WT, Psaty BM. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 63: 1868-1875, 2004.
15. Ebrahim S, Sung J, Song YM, Ferrer RL, Lawlor DA, Davey Smith G. Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ 333: 22-25, 2006.
16. Orken DN, Kenangil G, Celik M, et al. Association of low cholesterol with primary intracerebral haemorrhage: a case control study. Acta Neurol Scand 119: 151-154, 2009.
17. Noda H, Iso H, Irie F, et al. Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki Prefectural Health Study. Circulation 119: 2136-2145, 2009.
18. Woo D, Kissela BM, Khoury JC, et al. Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study. Stroke 35: 1360-1364, 2004.
19. Yokoyama S, Ikeda H, Haramaki N, Yasukawa H, Katoh A, Imai-zumi T. HMG-CoA reductase inhibitor protects against in vivo arterial thrombosis by augmenting platelet-derived nitric oxide release in rats. J Cardiovasc Pharmacol 45: 375-381, 2005.
20. Asahi M, Huang Z, Thomas S, et al. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab 25: 722-729, 2005.
21. Amarenco P, Bogousslavsky J, Callahan A III, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355: 549-559, 2006.
22. Leker RR, Khoury ST, Rafaeli G, Shwartz R, Eichel R, Tanne D; On behalf of the NASIS Investigators. Prior use of statins improves outcome in patients with intracerebral hemorrhage. Prospective data from the National Acute Stroke Israeli Surveys (NA-SIS). Stroke 40: 2581-2584, 2009.
23. Naval NS, Abdelhak TA, Zeballos P, Urrunaga N, Mirski MA, Carhuapoma JR. Prior statin use reduces mortality in intracerebral hemorrhage. Neurocrit Care 8: 6-12, 2008.
24. Naval NS, Abdelhak TA, Urrunaga N, Zeballos P, Mirski MA, Carhuapoma JR. An association of prior statin use with decreased perihematomal edema. Neurocrit Care 8: 13-18, 2008.
25. Gomis M, Ois A, Rodríguez-Campello A, et al. Outcome of in-tracerebral haemorrhage patients pre-treated with statins. Eur J Neurol 17: 443-448, 2010.
26. FitzMaurice E, Wendell L, Snider R, et al. Effect of statins on in-tracerebral hemorrhage outcome and recurrence. Stroke 39: 2151-2154, 2008.
27. Eichel R, Khoury ST, Ben-Hur T, Keidar M, Paniri R, Leker RR. Prior use of statins and outcome in patients with intracerebral haemorrhage. European Journal of Neurology 17: 78-83, 2010.
28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the con-centration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972.
29. Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27: 1304-1305, 1996.
30. Goldstein LB, Amarenco P, Szarek M, et al. Hemorrhagic stroke in the stroke prevention by aggressive Reduction in cholesterol levels study. Neurology 70: 2364-2370, 2008.
31. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366: 1267-1278, 2005.
32. Westover MB, Bianchi MT, Eckman MH, Greenberg SM. Statin use following intracerebral hemorrhage: A decision analysis. Arch Neurol 68: 573-579, 2011.